Literature DB >> 7810519

Renal replacement therapy in Canada: a report from the Canadian Organ Replacement Register.

S Fenton1, M Desmeules, P Copleston, G Arbus, D Froment, J Jeffery, C Kjellstrand.   

Abstract

We report here the demography and results of renal replacement therapy in Canada from 1981 to 1992. The new case rate for patients entering renal replacement therapy programs in Canada has increased dramatically over the last 12 years, from 49.9 per million to 98.4 per million of the population. The largest increases have been among the elderly, from 146.2 per million in 1981 to 381.9 per million in 1992 for those aged 65 to 74 years. There has been an even more dramatic increase for those over 75 years, from 83.6 per million in 1981 to 261.6 per million in 1992. There has been a similar increase in the prevalence rate, with an increase from 229.1 per million in 1981 to 518.5 per million in 1992. The hemodialysis rate for 1992 was 172.2 per million and that for peritoneal dialysis was 103.1 per million of the population. The renal transplantation rate also increased from 20 per million in 1981 to 34.8 per million in 1988, but unfortunately has decreased to 27.5 per million in 1992. Diabetes is now the most common primary renal diagnosis, having increased from 15% in 1981 to 24% in 1992. The 5-year survival rate of all patients on renal replacement therapy was 55%. For nondiabetic patients, the 5-year survival rate ranged from 85% for the those aged 15 to 44 years to 20% for those over 65 years. Among diabetic patients, the 5-year survival rate declined from 58% for the 15 to 44 year age group to 10% for those over 65 years.

Entities:  

Mesh:

Year:  1995        PMID: 7810519     DOI: 10.1016/0272-6386(95)90639-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

1.  Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes.

Authors:  H C Gerstein; S Meltzer
Journal:  CMAJ       Date:  1999-06-01       Impact factor: 8.262

2.  Cardiac disease in diabetic end-stage renal disease.

Authors:  R N Foley; B F Culleton; P S Parfrey; J D Harnett; G M Kent; D C Murray; P E Barre
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

3.  Primary Vesicoureteral reflux and chronic kidney disease in pediatric population. What we have learnt?

Authors:  Veridiana Andrioli; Rodrigo Regacini; Wilson Aguiar
Journal:  Int Braz J Urol       Date:  2020 Mar-Apr       Impact factor: 1.541

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.